Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcturus Therapeutics Holdings (ARCT) EV to EBIT (2022 - 2023)

Updated

Arcturus Therapeutics Holdings' EV to EBIT was 6.03 in Q3 2023, down 39.5% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) EV to EBIT (2022 - 2023) Analysis & Trends

On a trailing twelve-month basis, Arcturus Therapeutics Holdings' EV to EBIT was -10.93 through Sep 30, 2023; for FY2022, it came in at 4.80.

  • Quarterly EV to EBIT has moved between 3.99 (Q1 2023) and 9.96 (Q2 2023) over five years.
  • Per Business Quant data, ARCT's EV to EBIT in the three quarters before Q3 2023 was 9.96 (Q2 2023), 3.99 (Q1 2023) and 4.80 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arcturus Therapeutics Holdings 267.25 Mn -551.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 6.03
Jun 30, 2023 9.96
Mar 31, 2023 3.99
Dec 31, 2022 4.80
API Access

Arcturus Therapeutics Holdings EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ARCT&period=max&api_key=YOUR_API_KEY